FDA inspection
Raptim Research Pvt. Ltd.: FDA inspection ending Sep 14, 2022
FDA inspection 1181097 · No Action Indicated (NAI) · Navi Mumbai
Key facts
| Inspection ID | 1181097 |
|---|---|
| Firm | Raptim Research Pvt. Ltd. |
| FEI number | 3007267856 |
| Address | A - 226 Near Mahape Depot |
| City | Navi Mumbai |
| Country | India |
| Fiscal year | 2022 |
| Inspection end date | Sep 14, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data